Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2)

Title:: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2)
Document type:: Zeitschriftenaufsatz
Author(s):: Gabriele Multhoff, …, Michael Molls et al.
Journal title:: Clinical Cancer Research
Year:: 2020
Language:: en
Fulltext / DOI:: doi:10.1158/1078-0432.CCR-20-1141
Publisher:: American Association for Cancer Research
Print-ISSN:: 1078-0432
E-ISSN:: 1557-3265
Status:: Postprint / reviewed
BibTeX

Occurrences: